Olefin Cis-Dihydroxylation with Bio-Inspired Fe Catalysts
A R T I C L E S
prompted us and others23-27 to explore polydentate ligands with
a N,N,O donor set to assess how the introduction of an oxygen
ligand can affect the performance of the iron catalyst (Scheme
1, species 1-5 and 7-9). In our initial efforts, we designed
Ph-DPAH,25 a facial tridentate ligand providing a donor set with
two pyridines and an amide carbonyl, and showed that its
iron(II) complex 1 catalyzed the cis-dihydroxylation of 1-octene,
resulting in an unprecedentedly high 76% conversion of the
H2O2 oxidant to product. This paper reports on further explora-
tions of the catalytic chemistry of 1 and of related complexes
(Scheme 1), as well as detailed mechanistic studies that reveal
a novel oxidative mechanism involving an FeII/FeIV cycle.
Vacuo, yielding a brown oil. This oil was redissolved into CH2Cl2
and washed with 3 × 50 mL fractions of 1 M HCl. The collected
aqueous phases were rendered basic (pH ≈ 8) by treatment with
sat. NaHCO3 solution. Product was then extracted into CH2Cl2 and
dried by Na2SO4. Solvent was removed in Vacuo, yielding a light-
brown oil. Purified H3C-DPAH was obtained as a white powder
after recrystallization from hot MeOH in 30% yield. 1H NMR
(CDCl3, δ ppm from TMS): 8.55 (d, 2H), 7.91 (d, 1H), 7.64 (td,
2H), 7.43 (d, 2H), 7.16 (d, 2H), 6.22, (d, 1H), 2.15 (s, 3H). 13C
NMR (CDCl3): 169.61, 158.90, 149.27, 136.88, 122.51, 122.25,
59.08, 23.44. IR (in CD3CN soln): ν(CdO) 1677 cm-1
.
Synthesis of (Di-(2-pyridyl)methyl)trifluoroacetamide (F3C-
DPAH). To a solution containing 1.15 g (6.2 mmol) of di-(2-
pyridyl)methylamine in 3 mL of pyridine was added a solution of
0.52 mL (6.8 mmol) trifluoroacetic acid in 8 mL pyridine. This
mixture was heated to 80 °C, at which point a solution of 2.2 mL
(8.5 mmol) triphenyl phosphite in 5 mL of pyridine was added
over a two-hour period. This mixture was stirred for 24 h at 80 °C,
after which the solution was cooled to room temperature and solvent
was removed in Vacuo, yielding a brown oil. Purified F3C-DPAH
was obtained from a silica gel column eluted with a hexanes/ethyl
acetate gradient in 58% yield. 1H NMR (CDCl3, δ ppm from TMS):
9.07 (d, 1H), 8.57 (d, 2H), 7.67 (td, 2H), 7.40 (d, 2H), 7.21 (ddd,
2H), 6.17, (d, 1H). 13C NMR (CDCl3): 156.71, 149.18, 137.15,
122.97, 121.88, 117.69, 58.77. IR (in CD3CN soln): ν(CdO) 1728
Experimental Section
Materials and Synthesis. All reagents were purchased from
Aldrich and used as received unless otherwise noted. All olefin
substrates were passed over basic alumina immediately prior to use.
CH3CN was distilled from CaH2. H218O2 (90% 18O-enriched, 2 wt
% solution in H216O) and H218O (95% 18O enriched) were obtained
from ICON Isotopes. The syntheses of the di-(2-pyridyl)methyl-
amine synthon28 and [FeII(OTf)2 ·2NCCH3]29 have been reported
previously.
Syntheses of (Di-(2-pyridyl)methyl)-4-methoxybenzamide (4-
MeO-C6H4-DPAH) and (Di-(2-pyridyl)methyl)-4-(trifluoro-
methyl)benzamide (4-F3C-C6H4-DPAH). To a solution containing
either 7.8 mmol of 4-methoxybenzoyl chloride or 7.8 mmol of
4-(trifluoromethyl)benzoyl chloride and 1.3 mL of triethylamine
in 20 mL of THF was slowly added 1.46 g (7.8 mmol) of di-(2-
pyridyl)methylamine at 0 °C. With stirring, this mixture was
warmed to 60 °C and heated for 20 min, after which the solution
was cooled back to 0 °C and filtered to remove Et3N·HCl. THF
was removed to afford a cream-colored solid, which was redissolved
in CH2Cl2 and washed with NaOH. The organic layer was then
collected, and the solvent was removed in Vacuo. Purified products
were obtained as white powders after recrystallization from hot
MeOH. 4-MeO-C6H4-DPAH (70% yield): 1H NMR (CDCl3, δ ppm
from TMS): 8.68 (d, 1H), 8.58 (dm, 2H), 7.94 (dm, 2H), 7.66 (td,
2H), 7.5 (d, 4H), 7.17, (ddd, 2H), 6.39 (d, 1H), 3.86 (s, 3H). 13C
NMR (CDCl3): 166.13, 162.28, 159.11, 149.23, 136.91, 129.13,
126.59, 127.52, 122.25, 113.71, 59.32, 55.43. IR (in CD3CN soln):
cm-1
.
Syntheses of [FeII(4-MeO-C6H4-DPAH)2](OTf)2 (2), [FeII(4-
F3C-C6H4-DPAH)2](OTf)2 (3), [FeII(H3C-DPAH)2](OTf)2 (4),
and [FeII(F3C-DPAH)2](OTf)2 (5). In a N2-containing glovebox, a
mixture of the R-DPAH ligand (1.0 mmol) and FeII(OTf)2 ·2NCCH3
(0.5 mmol) was stirred for 5 h in 10 mL of CH3CN. A yellow-
green powder formed. Solvent was removed in Vacuo, and CH3CN
was added until the resulting solid was completely dissolved. For
2 and 3, vapor diffusion of Et2O into this solution at -20 °C resulted
in the formation of purified 2 after 5 days as bright green, block-
shaped single crystals in a 62% yield and purified 3 after 7 days as
bright yellow-green, plate-shaped single crystals in a 53% yield,
both suitable for X-ray crystallographic analysis. See Supporting
Information for details regarding X-ray crystallographic analysis
and Tables S1 and S2 for crystal data and structure refinement for
2 and 3. For 4 and 5, layering Et2O over the CH3CN solution resulted in
the formation of purified product after 1 day at -20 °C as a yellow-green
powder in 58% yield for 4 and 65% yield for 5. Characterization of 2:
ESI/MS: m/z 843 ([Fe(MeOC6H4-DPAH)2(OTf)]+), 524 ([Fe(MeOC6H4-
DPAH)(OTf)]+), 347 ([Fe(MeOC6H4-DPAH)2]2+), 320 ([(MeOC6H4-
DPAH)+H]+). Anal. Calcd (found) for C40H34F6FeN6O10S2: C, 48.40
(48.26); H, 3.45 (3.43); N, 8.47 (8.53); F, 11.48 (11.54). IR (in CD3CN
soln): ν(CdO) 1618 cm-1. Characterization of 3: ESI/MS: m/z
562 ([Fe(F3CC6H4-DPAH)(OTf)]+), 385 ([Fe(F3CC6H4-DPAH)2]2+),
358 ([(F3CC6H4-DPAH)+H]+). Anal. Calcd (found) for
C39H27F12FeN6O8S2: C, 44.96 (44.50); H, 2.64 (2.59); N, 7.86 (7.85);
1
ν(CdO) 1657 cm-1. 4-F3C-C6H4-DPAH (65% yield): H NMR
(CDCl3, δ ppm from TMS): 8.94 (d, 1H), 8.59 (d, 2H), 8.08 (d,
2H), 7.71 (m, 4H), 7.51 (d, 2H), 7.21, (ddd, 2H), 6.42 (d, 1H). 13
C
NMR (CDCl3): 165.20, 158.31, 149.07, 137.35, 136.97, 132.81,
127.65, 125.44, 122.61, 122.16, 59.16. IR (in CD3CN soln):
ν(CdO) 1668 cm-1
.
Synthesis of (Di-(2-pyridyl)methyl)acetamide (H3C-DPAH).
To a solution containing 0.88 g (4.8 mmol) of di-(2-pyridyl)-
methylamine in 2 mL of pyridine was added a solution of 0.3 mL
(5.2 mmol) of acetic acid in 5 mL of pyridine. This mixture was
heated to 80 °C, at which point a solution of 1.7 mL (6.5 mmol) of
triphenyl phosphite in 3 mL of pyridine was added over a 2 h period.
This mixture was stirred for 24 h at 80 °C, after which the solution
was cooled to room temperature and the solvent was removed in
F, 21.33 (21.32). IR (in CD3CN sol’n): ν(CdO) 1632 cm-1
.
Characterization of 4: ESI/MS: m/z 659 ([Fe(H3C-DPAH)2(OTf)]+),
432 ([Fe(H3C-DPAH)(OTf)]+), 255 ([Fe(H3C-DPAH)2]2+), 228
([(H3C-DPAH)+H]+). Anal. Calcd (found) for C28H26F6FeN6O8S2:
C, 41.60 (41.72); H, 3.24 (3.14); N, 10.39 (10.50); F, 14.10 (14.35).
IR (in CD3CN soln): ν(CdO) 1630 cm-1. Characterization of 5:
ESI/MS: m/z 617 ([Fe(F3C-DPAH)2-H]+), 486 ([Fe(F3C-DPA-
H)(OTf)]+), 377 ([Fe(F3C-DPAH)(NCCH3)-H]+), 304 ([(F3C-
DPAH)+Na]+), 282 ([(F3C-DPAH)+H]+). Anal. Calcd (found) for
C28H20F12FeN6O8S2 ·H2O: C, 36.70 (36.52); H, 2.20 (2.15); N, 9.17
(23) Beck, A.; Weibert, B.; Burzlaff, N. I. Eur. J. Inorg. Chem. 2001, 521–
527.
(24) Beck, A.; Barth, A.; Hu1bner, E.; Burzlaff, N. Inorg. Chem. 2003,
42, 7182–7188.
(25) Oldenburg, P. D.; Shteinman, A. A.; Que, L., Jr. J. Am. Chem. Soc.
2005, 127, 15672–15673.
(9.03); F, 24.88 (24.75). IR (in CD3CN soln): ν(CdO) 1633 cm-1
.
Instrumentation. 1H and 13C NMR spectra were recorded on a
Varian Unity 300 or 500 MHz spectrometer at ambient temperature.
Chemical shifts (ppm) were referenced to the residual protic solvent
peaks. FTIR spectra were obtained with a Thermo Nicolet Avatar
370 FT-IR instrument. X-ray crystallographic analyses were
completed by mounting the crystal on a Bruker-AXS platform
diffractometer with a CCD area detector and sealed-tube 3-KW
(26) Oldenburg, P. D.; Ke, C.-Y.; Tipton, A. A.; Shteinman, A. A.; Que,
L., Jr. Angew. Chem., Int. Ed. 2006, 45, 7975–7978.
(27) Bruijnincx, P. C. A.; Buurmans, I. L. C.; Gosiewska, S.; Moelands,
M. A. H.; Lutz, M.; Spek, A. L.; Koten, G. v.; Klein Gebbink, R. J. M.
Chem.sEur. J. 2008, 14, 1228–1237.
(28) Renz, M.; Hemmert, C.; Meunier, B. Eur. J. Org. Chem. 1998, 1271–
1273.
(29) Hagen, K. S. Inorg. Chem. 2000, 39, 5867–5869.
9
J. AM. CHEM. SOC. VOL. 132, NO. 50, 2010 17715